newsfilter
← Latest News
GlobeNewswire·

Progenics Pharmaceuticals Announces Delivery of Consents and Revocations to Independent Inspector of Elections

NEW YORK, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) (“Progenics” or the “Company”), an oncology company developing innovative targeted medicines and artificial...